灵尘居
-
1
农业银行银联/万事达/Visa双币尊然白金卡（精粹版）权益详解（2026年）
-
2
建设银行全球支付 Visa 白金卡权益详解（2026年）
-
3
邮储银行的鼎雅白金信用卡有哪些权益
-
4
GitHub 等免费代码补全插件推荐：Codeium、Tabnine、IntelliCode 全面对比
-
5
如何撤销 Trust Wallet 钱包 USDT（BEP-20）的 SWFT Bridgers 合约授权
-
6
香港中银零手续费无损汇款澳门蚂蚁银行教程，5分钟到账
-
7
香港汇丰汇款澳门蚂蚁银行教程，无手续费，3分钟到账
-
8
微信支付后摇一摇太烦人？一键关闭入口的链接
-
9
德国 Hetzner VPS升级到CPX22套餐
-
10
macOS Tahoe 26 重置蓝牙模块教程
反斗限免
-
1
限时免费获取 Epic 游戏 Alone With You[iOS、Android][¥15→0]
-
2
限时免费获取一年 Sticky Password Premium[Windows、macOS、iOS、Android][$39.99→0]
-
3
限时免费获取 Epic 游戏 Evan's Remains[iOS、Android][¥13→0]
-
4
Legacy - Reawakening - 遗产-重生[Android][$3.99→0]
-
5
Demon Hunter: Premium - 恶魔猎手[Android][$0.99→0]
-
6
Rogue Hearts - 侠盗的心[iOS、Android][美区 $0.99→0]
-
7
限时免费获取 Epic 游戏 Down in Bermuda 逃出百慕大[iOS、Android][¥18→0]
-
8
限时免费获取 Epic 游戏 Caravan SandWitch 漫漫长路 沙巫之旅[iOS、Android][¥25→0]
-
9
Data Defense - 数据防御[Android][$4.99→0]
-
10
Conversations (Jabber / XMPP) – 开源的 Jabber/XMPP 客户端[Android][$4.49→0]
Amazon Elastic Container Service for Kubernetes
-
1
Open Network User Group (ONUG) Fall Conference
-
2
Continuous Delivery with Amazon EKS and Jenkins X
-
3
Kubernetes Ingress with AWS ALB Ingress Controller
-
4
AWS at KubeCon + CloudNativeCon North America 2018
-
5
Announcing EKS Support in mu
-
6
Using Kubernetes Service Catalog and AWS Service Broker on EKS
-
7
KubeCon Seattle 2018 Recap
-
8
Top Posts of 2018
-
9
Demystifying ENTRYPOINT and CMD in Docker
-
10
Using Open Policy Agent on Amazon EKS
Annals of Oncology Current Issue
-
1
16P Neutrophil-lymphocyte ratio as a prognostic marker in a resource constraint setting for metastatic malignancies treated with immune checkpoint inhibitors
-
2
104P A novel immunological role of hydrogen sulphide in shaping natural killer cells cytoxicity in breast cancer patients
-
3
143P Association of PTPRT mutation with survival of immune checkpoint inhibitor in patients with cancer
-
4
11P PD-L1 profiling of circulating tumour cells is a viable companion diagnostic for checkpoint inhibitor therapy in lung cancer
-
5
85P Impact of digital patient monitoring (DPM) on quality of clinical care of cancer immunotherapy (CIT)-treated patients (pts) with advanced/metastatic non-small cell lung cancer (a/mNSCLC)
-
6
27P Single-nucleotide polymorphism variation (SNV): Possible candidates as predictive biomarkers to response and progression free survival (PFS) in cutaneous malignant melanoma (CMM) patients treated with immune checkpoint inhibitors (ICI)
-
7
33P Tumour mutational burden ring trial: Evaluation of targeted next-generation sequencing platforms for implementation in clinical practice
-
8
169P Impact of open-label design on patient-reported outcomes (PROs) data in randomized clinical trials of immuno-oncology (IO) agents in patients with advanced or metastatic cancer: A 10-year systematic literature review (SLR)
-
9
92O Nivolumab plus low-dose ipilimumab as first-line treatment of advanced NSCLC: Overall survival analysis of checkmate 817
-
10
40P Treatment of refractory recurrent gastrointestinal stromal tumors with adoptive cellular immunotherapy (TILs) and personalized vaccine